BAX Baxter International Inc

  1. Stocks
  2. Healthcare
  3. NYSE: BAX

Price (delayed)

$37.74

Market cap

$19.11B

P/E Ratio

N/A

Dividend/share

$1.16

EPS

-$5.65

Enterprise value

$34.31B

Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, it has been operating ...

Highlights
The revenue is up by 7% year-on-year
The company's equity fell by 37% YoY and by 5% QoQ
The quick ratio is down by 34% year-on-year and by 18% since the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.baxter.com
Peers: CAH BSX SYK BDX

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
506.4M
Market cap
$19.11B
Enterprise value
$34.31B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.43
Price to sales (P/S)
1.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.28
Earnings
Revenue
$15.02B
EBIT
-$2.35B
EBITDA
-$1.05B
Free cash flow
$863M
Per share
EPS
-$5.65
Free cash flow per share
$1.71
Book value per share
$11.01
Revenue per share
$29.68
TBVPS
$29.64
Balance sheet
Total assets
$27.89B
Total liabilities
$22.25B
Debt
$16.92B
Equity
$5.57B
Working capital
$2.44B
Liquidity
Debt to equity
3.04
Current ratio
1.42
Quick ratio
0.73
Net debt/EBITDA
-14.43
Margins
EBITDA margin
-7%
Gross margin
33.7%
Net margin
-19%
Operating margin
-15.2%
Efficiency
Return on assets
-10.2%
Return on equity
-50%
Return on invested capital
-9.3%
Return on capital employed
-10.6%
Return on sales
-15.6%
Dividend
Dividend yield
3.07%
DPS
$1.16
Payout ratio
N/A

BAX stock price

How has the Baxter International stock price performed over time
Intraday
0.53%
1 week
0.11%
1 month
-10.84%
1 year
-31.75%
YTD
-25.96%
QTD
-17.16%

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$15.02B
Gross profit
$5.05B
Operating income
-$2.28B
Net income
-$2.85B
Gross margin
33.7%
Net margin
-19%
BAX's net income is down by 16% since the previous quarter
Baxter International's net margin has decreased by 15% from the previous quarter
Baxter International's operating income has decreased by 14% from the previous quarter
The operating margin has decreased by 13% from the previous quarter

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
BAX P/E details
P/E
N/A
P/B
3.43
P/S
1.27
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.28
The EPS has contracted by 16% from the previous quarter
The company's equity fell by 37% YoY and by 5% QoQ
BAX's P/B is 29% below its 5-year quarterly average of 4.8 and 18% below its last 4 quarters average of 4.2
BAX's P/S is 59% below its 5-year quarterly average of 3.1 and 21% below its last 4 quarters average of 1.6
The revenue is up by 7% year-on-year

Efficiency

How efficient is Baxter International business performance
The company's return on equity fell by 33% QoQ
The ROIC has decreased by 22% from the previous quarter
The ROA has contracted by 20% from the previous quarter
The ROS has contracted by 18% from the previous quarter

Dividends

What is BAX's dividend history
Dividend details
DPS
$1.16
Dividend yield
3.07%
Payout ratio
N/A
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 25% more than the total liabilities
The quick ratio is down by 34% year-on-year and by 18% since the previous quarter
The current ratio fell by 29% YoY and by 16% QoQ
The debt to equity has surged by 57% year-on-year and by 6% since the previous quarter
The company's equity fell by 37% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.